Tag:
Transave
Latest Headlines
Latest Headlines
Insmed shares nosedive as regulators demand tox study on PhIII drug
Insmed's regulatory woes with the cystic fibrosis drug Arikace are continuing this morning with the news that the FDA will not release its hold on the late-stage trial for the treatment and is now
Insmed shares crater as FDA puts a clamp on Ph3 CF study
Just seven months after completing its takeover of Transave, Insmed is reporting that the FDA has put a clinical hold on the Phase III trial of Arikace, a late-stage cystic fibrosis drug that had
